Detection of lymphoma in bone marrow by whole-body positron emission tomography.
暂无分享,去创建一个
J. D. van der Walt | M. O'Doherty | S. Barrington | M J O'Doherty | C. Saunders | A. Timothy | R Carr | S F Barrington | B Madan | C A Saunders | J van der Walt | A R Timothy | B. Madan | R. Carr | Michael O'Doherty | Robert Carr | Sally Barrington | Bella Madan | Catherine A.B. Saunders | Jon van der Walt | Adrian R. Timothy | Sally F. Barrington
[1] S. Gregory,et al. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look. , 1989, Hematologic pathology.
[2] D. Weisenburger,et al. Mantle cell lymphoma-- an entity comes of age. , 1996, Blood.
[3] C. Fegan,et al. Mantle cell leukaemia? , 1996, British journal of haematology.
[4] M. Kaminski,et al. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. , 1994, Radiology.
[5] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[6] R. Musumeci,et al. New imaging techniques in staging lymphomas , 1994, Current opinion in oncology.
[7] S. Minoshima,et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] D. Lee,et al. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] M E Phelps,et al. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] C. Bloomfield,et al. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. , 1975, Annals of internal medicine.
[11] O. Warburg. On the origin of cancer cells. , 1956, Science.
[12] Elaine S. Jaffe,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[13] K. Någren,et al. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] V. Diehl,et al. Malignant lymphoma: bone marrow imaging versus biopsy. , 1989, Radiology.
[15] J H Thrall,et al. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. , 1993, Radiographics : a review publication of the Radiological Society of North America, Inc.
[16] R. Wahl. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] B F Hutton,et al. Simultaneous emission and transmission measurements for attenuation correction in whole-body PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] I. Magrath,et al. Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. , 2006, Medical and pediatric oncology.
[19] R. Castellino,et al. Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management. , 1989, Radiology.
[20] J. Itami,et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] H. Minn,et al. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. , 1995, Blood.
[22] M. Wolf,et al. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. , 1990, Journal of clinical pathology.
[23] B. Glimelius,et al. Predicting malignancy grade with PET in non-Hodgkin's lymphoma. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] M. Phelps,et al. Positron emission tomography scanning in cancer. , 1994, Cancer investigation.
[25] S. Barrington,et al. Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning. , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).
[26] R Paul,et al. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] S. Reske,et al. Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases. , 1993, Acta oncologica.
[28] E. Macintyre,et al. The value of staging bone marrow trephine biopsy in Hodgkin's Disease , 1987, European journal of haematology.
[29] A. Shields,et al. Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging , 1994, American journal of hematology.
[30] T. Fukumura,et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.